1. The prognostic value and response to immunotherapy of immunogenic cell death-associated genes in breast cancer
   Rongling Zhao et al, 2023, Frontiers in Oncology CrossRef
2. Tailored Bayes: a risk modeling framework under unequal misclassification costs
   Solon Karapanagiotis et al, 2022, Biostatistics CrossRef
3. Validity of the prognostication tool PREDICT version 2.2 in Japanese breast cancer patients
   Karen Zaguirre et al, 2021, Cancer Medicine CrossRef
4. Chemotherapy effectiveness in trial-underrepresented groups with early breast cancer: A retrospective cohort study
   Ewan Gray et al, 2019, PLOS Medicine CrossRef
5. Cancer of the Breast
   N. Lynn Henry et al, 2020, Abeloff's Clinical Oncology CrossRef
6. Clinical and molecular aspects of breast cancer: Targets and therapies
   R.L.N. Godone et al, 2018, Biomedicine & Pharmacotherapy CrossRef
7. Development and External Validation of Prediction Models for 10-Year Survival of Invasive Breast Cancer. Comparison with PREDICT and CancerMath
   Solon Karapanagiotis et al, 2018, Clinical Cancer Research CrossRef
8. An easy, fast, and accurate way for implementing the standards of care for the management of patients with endometrial carcinoma into daily clinical practice: the ESGO mobile app
   Thomas Gaillard et al, 2023, International Journal of Gynecologic Cancer CrossRef
9. Machine learning to guide the use of adjuvant therapies for breast cancer
   Ahmed M. Alaa et al, 2021, Nature Machine Intelligence CrossRef
10. Variation in chemotherapy prescribing rates and mortality in early breast cancer over two decades: a national data linkage study
    E. Gray et al, 2021, ESMO Open CrossRef
11. Insights into the performance of PREDICT tool in a large Mainland Chinese breast cancer cohort: a comparative analysis of versions 3.0 and 2.2
    Endong Chen et al, 2024, The Oncologist CrossRef
12. An updated PREDICT breast cancer prognostic model including the benefits and harms of radiotherapy
    Isabelle Grootes et al, 2024, npj Breast Cancer CrossRef
13. Do online prognostication tools represent a valid alternative to genomic profiling in the context of adjuvant treatment of early breast cancer? A systematic review of the literature
    Hiba El Hage Chehade et al, 2018, The American Journal of Surgery CrossRef
14. Impact of Oncotype DX breast Recurrence Score testing on adjuvant chemotherapy use in early breast cancer: Real world experience in Greater Manchester, UK
    J. Loncaster et al, 2017, European Journal of Surgical Oncology (EJSO) CrossRef
15. Opportunities and Challenges in Soft Tissue Sarcoma Risk Stratification in the Era of Personalised Medicine
    Avirup Chowdhury et al, 2024, Current Treatment Options in Oncology CrossRef